NeoGenomics, Inc. Other Current Assets
NeoGenomics, Inc. (NEO) had Other Current Assets of $9.81 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-07-28
- 2026-06-30: Other Assets, Current $9.81M.
- 2026-03-31: Other Assets, Current $6.61M.
- 2025-12-31: Other Assets, Current $7.42M.
- 2025-09-30: Other Assets, Current $10.53M.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $9.81M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $6.61M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $7.42M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $10.53M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $9.79M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $11.89M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $11.72M 10-K · filed 2026-02-17 |
| 2024-09-30 | $8.31M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $9.16M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $9.31M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $8.24M 10-K · filed 2025-02-18 |
| 2023-09-30 | $9.32M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $8.43M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $7.62M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $8.08M 10-K · filed 2024-02-20 |
| 2022-09-30 | $7.52M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.51M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $20.69M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $8.19M 10-K · filed 2023-02-24 |
| 2021-09-30 | $15.76M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $8.42M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.67M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.55M 10-K · filed 2022-02-25 |
| 2020-09-30 | $3.97M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $6.03M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $2.05M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $2.75M 10-K · filed 2021-02-25 |
| 2019-09-30 | $603.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $632.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.99M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $561.00K 10-K · filed 2020-02-28 |
| 2017-12-31 | $1.00M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |